A recent study revealed that HLA-B75, DR13 homozygosity, or DR- 14 increased the risk of allopurinol-induced SJS/TEN when combined with HLA-B*5801, especially in patients with impaired renal function (14, 16). This evidence concerns the gene HLA-B and toxic epidermal necrolysis.